placeholder
Submental fullness due to submental fat, often referred to as a “double chin,” is a common condition that affects men and women of all ages.
Genetics, aging and weight gain can play a role in submental fullness, which is often resistant to diet and exercise. The double chin has also historically been an under-treated facial aesthetic condition, despite 2014 survey results from the American Society for Dermatologic Surgery (ASDC), which indicate that over two-thirds of consumers are bothered by their double chins.
KYBELLA™ (deoxycholic acid) injections can help with double-chin removal. KYBELLA is the first and only FDA-approved injectable drug that contours and improves the appearance of fullness due to submental fat.KYBELLA™ is the only FDA approved injectable liposuction on the market. Intended to erase double chins, it is an enzyme that will eat away your fat cells and your body will metabolize them. Kybella underwent over 4 years of rigorous human clinical trials. Over 1500 patients were enrolled and treated in the clinical trials and the FDA advisory committee voted unanimously for its approval this past May. Kybella’s safety profile proved exceptional with no permanent adverse effects.
WHAT IS KYBELLA™?
KYBELLA™ is the first FDA-approved injectable treatment for permanently reducing submental fat (aka the double chin).
HOW DOES IT WORK?
Deoxycholic acid, the active ingredient in KYBELLA™(and a naturally-occurring molecule), aids in the breakdown and absorption of fat cells. Once destroyed, these cells are permanently eliminated through the body and the appearance of the double chin/neck wattle is improved. A series of injections are administered at each treatment session. KYBELLA™ treatments typically last 20-30 minutes and are spaced out at least 6-8 weeks apart. A traditional KYBELLA™ cycle can require up to 6 total treatments, however, patients see visible contouring in two to four sessions. Some results are visible weeks after treatment, however, final contouring with skin retraction is seen three months after final session.
KYBELLA™ can achieve long-lasting results, due to the fact that fat cells are permanently removed from beneath the chin after treatment. Sabrina Mercer Skincare can help create a personalized KYBELLA™treatment plan to fit your individual needs.
HOW LONG DO THE TREATMENTS TAKE, HOW MANY TREATMENTS ARE NEEDED, AND ARE THE RESULTS PERMANENT?
The amount of treatments varies depending on the amount of fat being treated. The average patient requires between 2 to 5 treatments. Treatments take 20-30 minutes and are spaced 1 month apart. The treatments are done in the office with just a simple use of topical anesthesia. The fat reduction results are permanent! Just like surgical liposuction, even if you gain additional weight after the procedure, the treated area will not gain as much fat back exponentially as other areas of the body because the number of fat cells have been permanently reduced.
WHAT SHOULD MY TREATMENT EXPECTATIONS BE: BEFORE, DURING AND AFTER? WILL I HAVE LOOSE SKIN AFTERWARDS?
A tiny needle is used to inject KYBELLA™ medication in a grid like pattern covering the area of excess fat under the chin. These injections will cause temporary minor discomfort. Mild to moderate swelling, redness, bruising, and pain/tenderness can be expected for 5-10 days after each treatment. These side effects are due to the destruction of the fat cells and the body’s natural tissue injury repair process. These side effects may even lead to tightening of the skin after the fat dissipates. Less common side effects may be: temporary numbness in the treated area that resolves within weeks to months or small, firm tender lumps/nodules. These bumps will also resolve over several weeks to months. In general, treatments are well tolerated and become even easier with each subsequent treatment.
WHY CHOOSE TO DO YOUR KYBELLA TREATMENTS WITH SKNCRAFT?
Sabrina Mercer RN, BSN, CANS, was chosen as one of the first providers to be trained in this nonsurgical neck liposuction injectable by Allergan, the maker of BOTOX, Juvederm and Voluma.
KYBELLA™ FACTS
KYBELLA™is the first and only FDA-approved injectable drug that contours and improves the appearance of submental fullness due to submental fat.
KYBELLA™ contains a non-human, non-animal formulation of deoxycholic acid, a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat.
KYBELLA™is administered by a trained healthcare professional using injections into the fat under the chin.
Each in-office KYBELLA treatment session typically takes 20-30 minutes.
Treatment with KYBELLA™ is customized by providers to address each patient’s aesthetic goals for an improved chin profile. KYBELLA cost varies based on each individual’s treatment needs.
Many patients experience visible results with two to four KYBELLA™treatment sessions spaced at least one month apart.
Up to a total of six KYBELLA™ treatments may be administered.
Once the aesthetic outcome is achieved, the need for KYBELLA™re-treatment is not expected, as KYBELLA™ causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat.
KYBELLA™as a non-surgical option for facial rejuvenation requires less recovery time than surgical options.
For most patients, downtime following a treatment session with KYBELLA™is minimal.
KYBELLA® (deoxycholic acid) injection 10 mg/mL Important Information
INDICATION
KYBELLA® (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.
The safe and effective use of KYBELLA® for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.
IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS
KYBELLA® is contraindicated in the presence of infection at the injection sites.
WARNINGS AND PRECAUTIONS
Marginal Mandibular Nerve Injury
Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness, were reported in 4% of subjects in the clinical trials; all cases resolved spontaneously (range 1-298 days, median 44 days). KYBELLA® should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.
Dysphagia
Dysphagia occurred in 2% of subjects in the clinical trials in the setting of administration-site reactions, eg, pain, swelling, and induration of the submental area; all cases of dysphagia resolved spontaneously (range 1-81 days, median 3 days). Avoid use of KYBELLA® in patients with current or prior history of dysphagia as treatment may exacerbate the condition.
Injection-Site Hematoma/Bruising
In clinical trials, 72% of subjects treated with KYBELLA® experienced hematoma/bruising. KYBELLA® should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur.
Risk of Injecting Into or in Proximity to Vulnerable Anatomic Structures
To avoid the potential of tissue damage, KYBELLA® should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles. Care should be taken to avoid inadvertent injection directly into an artery or a vein as it can result in vascular injury.
Injection Site Alopecia
Cases of injection site alopecia have been reported with administration of KYBELLA®. Onset and duration may vary among individuals and may persist. Consider withholding subsequent treatments until resolution.
Injection Site Ulceration and Necrosis
Injections that are too superficial into the dermis may result in skin ulceration and necrosis. Cases of injection site ulceration, necrosis, and infection have been reported with administration of KYBELLA®. Do not administer KYBELLA® into affected area until complete resolution.
ADVERSE REACTIONS
The most commonly reported adverse reactions in the pivotal clinical trials were: injection site edema/swelling, hematoma/bruising, pain, numbness, erythema, and induration.
Please see KYBELLA® full Prescribing Information.
ph
ph
Placeholder
Botox Cosmetic, or Botulinum Toxin, is the first and only treatment FDA-approved to make temporarily moderate to severe frown lines, crow’s feet, and forehead lines look better in adults
The amount of product varies per person and will depend on your muscle's strength and aesthetic preference.
At the time of your appointment, your provider will review your dosage in depth with you.
Results can be seen within the first 24-48 hours. However, results will take full effect 14 days post-treatment
Results last up to 4 months for moderate to severe frown lines and will vary per person.
It is always recommended to plan your next treatment with your provider
Most clients think the injections feel like a light “pinch.” However, we are all about comfort and have
a high-tech chilling machine that adds extra comfort to the treatment area
Once you’ve completed a consultation, the process is quick and easy!
Your appointment will take 15 to 30 minutes max
Yes! While we always recommend speaking with your provider before scheduling,
we are more than happy to accommodate more than one treatment
Sorry, Mama! We don’t currently offer nor recommend any services that are safe if pregnant or breastfeeding.
Let us help you stay on track and create a custom treatment plan for the future.
Schedule online anytime by engaging with the SKNCRAFT chat box located at the bottom right corner, simply type "schedule appointment" to get started or feel free to call or text 281-256-1003
